Immunocore Holdings plc

NasdaqGS:IMCR Stock Report

Market Cap: US$3.1b

Immunocore Holdings Future Growth

Future criteria checks 1/6

Immunocore Holdings is forecast to grow earnings and revenue by 27.2% and 19.8% per annum respectively. EPS is expected to grow by 26.4% per annum. Return on equity is forecast to be -183.1% in 3 years.

Key information

27.2%

Earnings growth rate

26.4%

EPS growth rate

Biotechs earnings growth20.6%
Revenue growth rate19.8%
Future return on equity-183.1%
Analyst coverage

Good

Last updated20 Mar 2024

Recent future growth updates

Recent updates

Here's Why Immunocore Holdings (NASDAQ:IMCR) Can Manage Its Debt Despite Losing Money

Jan 22
Here's Why Immunocore Holdings (NASDAQ:IMCR) Can Manage Its Debt Despite Losing Money

Immunocore Holdings: Vulnerable To Profit Taking After Big Rally

Jan 21

Revenues Not Telling The Story For Immunocore Holdings plc (NASDAQ:IMCR) After Shares Rise 37%

Dec 18
Revenues Not Telling The Story For Immunocore Holdings plc (NASDAQ:IMCR) After Shares Rise 37%

Some Confidence Is Lacking In Immunocore Holdings plc's (NASDAQ:IMCR) P/S

May 08
Some Confidence Is Lacking In Immunocore Holdings plc's (NASDAQ:IMCR) P/S

Forecast: Analysts Think Immunocore Holdings plc's (NASDAQ:IMCR) Business Prospects Have Improved Drastically

Nov 16
Forecast: Analysts Think Immunocore Holdings plc's (NASDAQ:IMCR) Business Prospects Have Improved Drastically

Immunocore: Attractive Commercial-Stage Biopharma

Oct 05

Need To Know: Analysts Are Much More Bullish On Immunocore Holdings plc (NASDAQ:IMCR)

Aug 12
Need To Know: Analysts Are Much More Bullish On Immunocore Holdings plc (NASDAQ:IMCR)

Immunocore GAAP EPS of -$0.17, revenue of $38.92M

Aug 10

Immunocore to raise $140M in private placement financing

Jul 18

Analysts Are Updating Their Immunocore Holdings plc (NASDAQ:IMCR) Estimates After Its Second-Quarter Results

Aug 15
Analysts Are Updating Their Immunocore Holdings plc (NASDAQ:IMCR) Estimates After Its Second-Quarter Results

Industry Analysts Just Upgraded Their Immunocore Holdings plc (NASDAQ:IMCR) Revenue Forecasts By 12%

May 20
Industry Analysts Just Upgraded Their Immunocore Holdings plc (NASDAQ:IMCR) Revenue Forecasts By 12%

Earnings and Revenue Growth Forecasts

NasdaqGS:IMCR - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026335-153-127-10010
12/31/2025311-115-105-9115
12/31/2024293-91-52-2116
12/31/2023249-55-23N/A
9/30/2023234-661421N/A
6/30/2023231-632026N/A
3/31/2023205-521117N/A
12/31/2022174-53-51-49N/A
9/30/2022114-62-55-54N/A
6/30/202282-112-96-94N/A
3/31/202253-156-134-133N/A
12/31/202136-180-144-143N/A
9/30/202137-150-137-135N/A
6/30/202139-139-111-110N/A
3/31/202142-116-83-78N/A
12/31/202041-101-88-84N/A
9/30/202037-105-91-86N/A
6/30/202034-109-137-131N/A
3/31/202033-120-146-141N/A
12/31/201934-138-142-136N/A
12/31/201830-91-26-21N/A
12/31/201719-66-107-82N/A
12/31/201620-29N/A-45N/A
12/31/20151720N/A-26N/A
9/30/201410-9N/A65N/A
9/30/20133-6N/A18N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: IMCR is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: IMCR is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: IMCR is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: IMCR's revenue (19.8% per year) is forecast to grow faster than the US market (8.2% per year).

High Growth Revenue: IMCR's revenue (19.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: IMCR is forecast to be unprofitable in 3 years.


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.